Table 1 Clinical characteristics of the study patients.
| Total population (n = 76) | Conventional group (n = 38) | Thrombectomy group (n = 38) | |
|---|---|---|---|
| Age (years) | 65.3 (11.2) | 64.6 (12.5) | 66.7 (14.1) |
| Men | 48 (63.1%) | 21 (55.3%) | 27 (71%) |
| Risk factors | |||
| Hypertension | 34 (44.7%) | 19 (50%) | 15 (39.5%) |
| Diabetes | 16 (21%) | 7 (18.4%) | 9 (23.7%) |
| Smoking | 17 (22.4%) | 10 (26.3%) | 7 (18.4%) |
| Obesity | 4 (5.3) | 1 (2.6) | 3 (7.9) |
| Family history of CAD | 19 (25%) | 14 (36.8%) | 5 (13.1%)* |
| Cholesterol (mmol/l) | 4.22 (0.70) | 4.32 (0.39) | 4.17 (0.28)* |
| Triglycerides (mmol/l) | 1.38 (0.42) | 1.41 (0.29) | 1.37 (0.44) |
| Renal failure | 8 (10.5%) | 3 (7.9%) | 5 (13.1%) |
| Killip class III | 19 (25%) | 11 (28.9%) | 8 (21%) |
| Previous PCI | 11 (14.5%) | 4 (10.5%) | 7 (18.4%) |
| Symptoms to balloon (hours) | 7.3 (1.3) | 7.6 (1.8) | 7.2 (1.9) |
| Medications at follow up | |||
| ACE‐I/ARBs | 67 (88.1%) | 31 (81.6%) | 36 (94.7%) |
| Aldosterone blockers | 41 (53.9%) | 22 (57.9%) | 19 (50%) |
| β Blockers | 58 (76.3%) | 27 (71%) | 31 (81.6%) |
| Statins | 68 (89.5%) | 36 (94.7%) | 32 (84.2%) |
| Aspirin | 74 (97.4%) | 37 (97.4%) | 37 (97.4%) |
Data are mean (SD) or number (%).
*p<0.05 between conventional and thrombectomy groups.
ACE‐I, angiotensin converting enzyme inhibitors; ARBs, angiotensin receptor blockers; CAD, coronary artery disease; PCI, percutaneous coronary angioplasty.